SCHEMBL7985986

SCHEMBL7985986

CN(CCCc1ccccc1)C(=O)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 2/20 0.54
FAAH O00519 3/20 0.51
CES1 P23141 3/20 0.51
TACR1 P25103 2/20 0.50
AOC3 Q16853 1/20 0.50
SIGMAR1 Q99720 1/20 0.49
ALOX5 P09917 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6463897 0.95 FAAH (0.54) MLYCDFAAHCES1SIGMAR1ALOX5
SCHEMBL13181406 0.90 MLYCD (0.64) MLYCDFAAHCES1TACR1AOC3
SCHEMBL2422928 0.81 AOC3 (0.58) AOC3SIGMAR1ALOX5
SCHEMBL11796587 0.81 PTGIR (0.48)
SCHEMBL2316926 0.80 RIPK1 (0.65) MLYCD
SCHEMBL8863944 0.77 MLYCD (0.60) MLYCDAOC3SIGMAR1
SCHEMBL12393190 0.76 CTSK (0.46) MLYCDFAAHCES1
SCHEMBL8751616 0.76 SIGMAR1 (0.61) AOC3SIGMAR1ALOX5
SCHEMBL29178457 0.75 AOC3 (0.56) AOC3SIGMAR1ALOX5
SCHEMBL12169769 0.75 AOC3 (0.51) AOC3SIGMAR1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
CN-1223659-A Fused imidazopyridine derivatives as antihyperlipidemic agents TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1999-07-21 CN disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed